Ghent University Academic Bibliography

Validation of postinduction Curie scores in high-risk neuroblastoma : a Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1

Gregory A Yanik, Marguerite T Parisi, Arlene Naranjo, Helen Nadel, Michael J Gelfand, Julie R Park, Ruth L Ladenstein, Ulrike Poetschger, Ariane Boubaker, Dominique Valteau-Couanet, et al.

(2018) JOURNAL OF NUCLEAR MEDICINE. 59(3). p.502-508

Add to list

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations : the SIOPEN/HR-NBL1 and COG-A3973 trials

Ruth Ladenstein, Bieke Lambert (UGent) , Ulrike Potschger, Maria-Rita Castellani, Valerie Lewington, Zvi Bar-Sever, Aurore Oudoux, Anna Sliwinska, Katerina Taborska, Lorenzo Biassoni, et al.

(2018) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 45(2). p.292-305

Add to list

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

C Piette, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, G Plat, N Dastugue, F Mazingue, et al.

(2018) LEUKEMIA. 32(1). p.244-248

Add to list

Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Daniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, et al.

(2018) PEDIATRIC BLOOD & CANCER. 65(11).

Add to list

Journal Article
A1
open access

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Stefan Bourgeois, Hans Van Vlierberghe (UGent) , Christophe Moreno, Hans Orlent, Frederik Nevens, Keikawus Arastéh, Yves Horsmans, Jörn M Schattenberg, Peter Buggisch, Sven Francque, et al.

(2017) BMC GASTROENTEROLOGY. 17.

Add to list

Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques

Sjouke Vandenberghe (UGent) , Luc Duchateau (UGent) , Leen Slaets, Jan Bogaerts and Stijn Vansteelandt (UGent)

(2017) STATISTICAL METHODS IN MEDICAL RESEARCH. 27(11). p.3367-3385

Add to list

Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

JA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, P Hillmen, NL Bartlett, J Li, et al.

(2015) NEW ENGLAND JOURNAL OF MEDICINE. 373(25). p.2425-2437

Add to list

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Arnaud M Didierlaurent, Catherine Collignon, Patricia Bourguignon, Sandrine Wouters, Kaat Fierens (UGent) , Michel Fochesato, Najoua Dendouga, Christelle Langlet, Bernard Malissen, Bart Lambrecht (UGent) , et al.

(2014) JOURNAL OF IMMUNOLOGY. 193(4). p.1920-1930

Add to list

Journal Article
A1
open access

Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines : randomized, double-blind study in malaria-naïve adults

Geert Leroux-Roels (UGent) , Isabel Leroux-Roels (UGent) , Frédéric Clement (UGent) , Opokua Ofori-Anyinam, Marc Lievens, Erik Jongert, Philippe Moris, W Ripley Ballou and Joe Cohen

(2014) HUMAN VACCINES & IMMUNOTHERAPEUTICS. 10(8). p.2211-2219

Add to list

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Nicole Dastugue, Stefan Suciu, Geneviève Plat, Franki Speleman (UGent) , Hélène Cavé, Sandrine Girard, Marleen Bakkus, Marie Pierre Pagès, Karima Yakouben, Brigitte Nelken, et al.

(2013) BLOOD. 121(13). p.2415-2423

Academic Bibliography

Validation of postinduction Curie scores in high-risk neuroblastoma : a Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations : the SIOPEN/HR-NBL1 and COG-A3973 trials

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques

Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines : randomized, double-blind study in malaria-naïve adults

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Contents

Support

Contact